title: Hemoglobin level and risk of hospitalization and mortality in children on peritoneal dialysis.
abstract: BACKGROUND
  Clinical practice guidelines for management of anemia in children with end-stage kidney disease (ESKD) remain largely opinion-based. In this study, we evaluated the risk of mortality and hospitalization by hemoglobin (Hb) level in a large prevalent population of U.S. children on peritoneal dialysis (PD).
  
  
  METHODS
  Hemoglobin levels in prevalent PD patients from the 2005 End Stage Renal Disease Clinical Performance Measures Project were linked with 5-year mortality and 4-year hospitalization records from the United States Renal Data System.
  
  
  RESULTS
  Of the 468 patients included in the study, the mean age was 11 years, 55 % were male, 67 % were white, 254 (54 %) were hospitalized, and 23 (5 %) died. Median (interquartile range) Hb levels were 11.7 (10.7-12.6) g/dl, and 30 % had Hb levels of <11 g/dl. In adjusted survival analysis, Hb thresholds of 10, 11, or 12 g/dl were not associated with a significant difference in risk of death. The incidence rate ratio (IRR) of hospitalization for patients with a mean Hb of ≥11 g/dl was 0.56 (95 % CI 0.43-0.73). Compared to a reference range of Hb of 11 to <12, Hb of ≥12 g/dl was not associated with a significant difference in hospitalization risk (IRR 0.88; 95 % CI 0.61-1.25). Using age- and sex specific cut-offs for anemia, children who were not anemic had a 27 % decreased risk of hospitalization compared to those with anemia (IRR 0.73; 95 % CI 0.55-0.97). Compared to the first erythropoiesis stimulating agent (ESA) dosing quartile, higher ESA doses were associated with an increased risk of both hospitalization and mortality.
  
  
  CONCLUSIONS
  U.S. children on PD with Hb levels of ≥11 g/dl were less likely to be hospitalized but had no observed difference in mortality. Children who were not anemic were also less likely to be hospitalized. Further study is necessary to elucidate whether a single optimal Hb level or a range applies to the pediatric ESKD population.
authors.affiliation: Division of Pediatric Nephrology, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD, 21201, USA, edahlinghaus@peds.umaryland.edu.
authors.forename: Erin K
authors.initials: EK
authors.lastname: Dahlinghaus
authors.forename: Alicia M
authors.initials: AM
authors.lastname: Neu
authors.forename: Meredith A
authors.initials: MA
authors.lastname: Atkinson
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Fadrowski
mesh_terms: D002648:Child; D015331:Cohort Studies; D005260:Female; D006454:Hemoglobins / Q000032:analysis*; D006760:Hospitalization; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000401:mortality*; D008297:Male; D010530:Peritoneal Dialysis / Q000009:adverse effects* / Q000401:mortality*; D016016:Proportional Hazards Models; D012189:Retrospective Studies
chemical_list: D006454:Hemoglobins
references.citation: Kidney Int. 2002 Feb;61(2):630-7
references.pmid: 11849406
references.citation: Kidney Int. 2005 May;67(5):2032-8
references.pmid: 15840054
references.citation: J Am Soc Nephrol. 2013 Mar;24(4):665-76
references.pmid: 23471197
references.citation: Am J Kidney Dis. 2004 Dec;44(6):1017-23
references.pmid: 15558522
references.citation: Nephrol Dial Transplant. 2012 Oct;27(10):3950-7
references.pmid: 22740719
references.citation: J Am Soc Nephrol. 2010 Jan;21(1):137-44
references.pmid: 19917781
references.citation: Exp Hematol. 1996 Feb;24(2):392-7
references.pmid: 8641371
references.citation: N Engl J Med. 1998 Aug 27;339(9):584-90
references.pmid: 9718377
references.citation: Am J Kidney Dis. 2011 Sep;58(3):418-28
references.pmid: 21601335
references.citation: Pediatr Nephrol. 2010 Nov;25(11):2335-41
references.pmid: 20668886
references.citation: Pediatr Nephrol. 2004 Sep;19(9):1029-34
references.pmid: 15241675
references.citation: Pediatr Nephrol. 2008 Jan;23(1):123-7
references.pmid: 17934888
references.citation: J Am Soc Nephrol. 2006 Jan;17(1):285-93
references.pmid: 16319190
references.citation: Pediatr Nephrol. 2010 Sep;25(9):1699-706
references.pmid: 20464428
references.citation: Pediatr Nephrol. 2006 Jun;21(6):793-9
references.pmid: 16583244
references.citation: Kidney Int. 2008 Sep;74(6):791-8
references.pmid: 18596733
references.citation: Am J Kidney Dis. 2004 Nov;44(5):866-76
references.pmid: 15492953
references.citation: N Engl J Med. 2006 Nov 16;355(20):2085-98
references.pmid: 17108343
references.citation: J Am Soc Nephrol. 2006 Oct;17(10):2878-85
references.pmid: 16943308
references.citation: Am J Kidney Dis. 2004 Jul;44(1):94-111
references.pmid: 15211443
references.citation: Kidney Int. 2008 Nov;74(10):1237-40
references.pmid: 18596731
references.citation: Am J Kidney Dis. 2009 Jul;54(1):59-69
references.pmid: 19501439
references.citation: N Engl J Med. 2010 Sep 16;363(12):1146-55
references.pmid: 20843249
references.citation: Pediatr Nephrol. 2007 Apr;22(4):565-72
references.pmid: 17180361
references.citation: Pediatr Nephrol. 2003 Oct;18(10):1055-62
references.pmid: 12883982
references.citation: Vital Health Stat 11. 2005 Mar;(247):1-156
references.pmid: 15782774
references.citation: Nephrol Dial Transplant. 2009 Apr;24(4):1082-8
references.pmid: 18987263
references.citation: Kidney Int. 2003 May;63(5):1908-14
references.pmid: 12675871
references.citation: Am J Kidney Dis. 2007 Dec;50(6):958-66
references.pmid: 18037097
references.citation: Clin J Am Soc Nephrol. 2008 May;3(3):759-67
references.pmid: 18287254
references.citation: Kidney Int. 2004 May;65(5):1864-9
references.pmid: 15086928
references.citation: Pediatr Nephrol. 2003 Aug;18(8):805-9
references.pmid: 12750985
references.citation: Clin J Am Soc Nephrol. 2009 Jan;4(1):48-56
references.pmid: 19056614
references.citation: Am J Kidney Dis. 2007 Sep;50(3):471-530
references.pmid: 17720528
references.citation: Nephrol Dial Transplant. 2000 Sep;15(9):1425-30
references.pmid: 10978402